Improvement of antitumor activity of photodynamic therapy through inhibition of cytoprotective mechanism in tumor cells

Progress in Biomedical Optics and Imaging - Proceedings of SPIE

Volumn 7380, Issue , 2009, Pages

  Nowis, Dominika ^a   Szokalska, Angelika ^a   Makowski, Marcin ^a   Winiarska, Magdalena ^a   Golab, Jakub ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

cyclooxygenase; cytoprotection; endoplasmic reticulum stress; heme oxygenase; photodynamic therapy; reactive oxygen species; superoxide dismutase; ubiquitin proteasome system

Indexed keywords

CYCLOOXYGENASES; CYTOPROTECTION; ENDOPLASMIC RETICULUM STRESS; HEME OXYGENASES; REACTIVE OXYGEN SPECIES; SUPER OXIDE DISMUTASE; UBIQUITIN-PROTEASOME SYSTEM;

CARBONYLATION; GENE THERAPY; MOLECULAR BIOLOGY; OXYGEN; PLASMONS; PORPHYRINS; TRANSCRIPTION; TRANSCRIPTION FACTORS; TUMORS;

PHOTODYNAMIC THERAPY;

EID: 79959685891     PISSN: 16057422     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1117/12.822929     Document Type: Conference Paper

References (42)

1. T. J. Dougherty, C. J. Gomer, B. W. Henderson et al., "Photodynamic therapy," J Natl Cancer Inst, 90(12), 889-905 (1998).
2. M. Makowski, Nowis, D., Golab, J., [Cytoprotective mechanisms in photodynamic therapy] Research Signpost, Kerala(2007).
3. Z. Huang, Li, L., Wang, H., Wang, X., Yuan, K., Meyers, A., Yang, L., Hetzel, FW. , "Photodynamic therapy - an update on clinical applications," Journal of Innovative Optical Health Sciences, 2(1), 73-92 (2009).
4. M. C. Luna, A. Ferrario, N. Rucker et al., "Decreased expression and function of alpha-2 macroglobulin receptor/low density lipoprotein receptor-related protein in photodynamic therapy-resistant mouse tumor cells," Cancer Res, 55(9), 1820-3 (1995).
5. D. Nowis, Golab, J., [Photodynamic therapy and oxidative stress] Artech House, Boston, London, 8 (2008).
6. R. Noor, S. Mittal, and J. Iqbal, "Superoxide dismutase - applications and relevance to human diseases," Med Sci Monit, 8(9), RA210-5 (2002).
7. D. Salvemini, D. P. Riley, and S. Cuzzocrea, "SOD mimetics are coming of age," Nat Rev Drug Discov, 1(5), 367-74 (2002).
8. H. Das, T. Koizumi, T. Sugimoto et al., "Induction of apoptosis and manganese superoxide dismutase gene by photodynamic therapy in cervical carcinoma cell lines," Int J Clin Oncol(5), 97-103 (2000).
9. J. Golab, D. Nowis, M. Skrzycki et al., "Antitumor effects of photodynamic therapy are potentiated by 2-methoxyestradiol. A superoxide dismutase inhibitor," J Biol Chem, 278(1), 407-14 (2003).
10. V. Dolgachev, L. W. Oberley, T. T. Huang et al., "A role for manganese superoxide dismutase in apoptosis after photosensitization," Biochem Biophys Res Commun, 332(2), 411-7 (2005).
11. M. Athar, H. Mukhtar, C. A. Elmets et al., "In situ evidence for the involvement of superoxide anions in cutaneous porphyrin photosensitization, " Biochem Biophys Res Commun, 151(3), 1054-9 (1988).
12. M. Korbelik, C. S. Parkins, H. Shibuya et al., "Nitric oxide production by tumour tissue: impact on the response to photodynamic therapy," Br J Cancer, 82(11), 1835-43 (2000).
13. S. W. Ryter, D. Morse, and A. M. Choi, "Carbon monoxide and bilirubin: potential therapies for pulmonary/vascular injury and disease," Am J Respir Cell Mol Biol, 36(2), 175-82 (2007).
14. D. Nowis, M. Legat, T. Grzela et al., "Heme oxygenase-1 protects tumor cells against photodynamic therapy-mediated cytotoxicity," Oncogene, 25(24), 3365-74 (2006).
15. C. J. Gomer, M. Luna, A. Ferrario et al., "Increased transcription and translation of heme oxygenase in Chinese hamster fibroblasts following photodynamic stress or Photofrin II incubation," Photochem Photobiol, 53(2), 275-9 (1991).
16. D. Bressoud, V. Jomini, and R. M. Tyrrell, "Dark induction of haem oxygenase messenger RNA by haematoporphyrin derivative and zinc phthalocyanine; agents for photodynamic therapy," J Photochem Photobiol B, 14(4), 311-8 (1992).
17. S. Kocanova, E. Buytaert, J. Y. Matroule et al., "Induction of heme-oxygenase 1 requires the p38MAPK and PI3K pathways and suppresses apoptotic cell death following hypericin-mediated photodynamic therapy," Apoptosis, 12(4), 731-41 (2007).
18. M. Niziolek, W. Korytowski, and A. W. Girotti, "Nitric oxide-induced resistance to lethal photooxidative damage in a breast tumor cell line," Free Radic Biol Med, 40(8), 1323-31 (2006).
19. F. Lin, and A. W. Girotti, "Hemin-enhanced resistance of human leukemia cells to oxidative killing: antisense determination of ferritin involvement," Arch Biochem Biophys, 352(1), 51-8 (1998).
20. T. Hida, K. Kozaki, H. Ito et al., "Significant growth inhibition of human lung cancer cells both in vitro and in vivo by the combined use of a selective cyclooxygenase 2 inhibitor, JTE-522, and conventional anticancer agents," Clin Cancer Res, 8(7), 2443-7 (2002).
21. L. Milas, K. Kishi, N. Hunter et al., "Enhancement of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzyme," J Natl Cancer Inst, 91(17), 1501-4 (1999).
22. A. Ferrario, K. Von Tiehl, S. Wong et al., "Cyclooxygenase-2 inhibitor treatment enhances photodynamic therapy-mediated tumor response," Cancer Res, 62(14), 3956-61 (2002).
23. M. Makowski, T. Grzela, J. Niderla et al., "Inhibition of cyclooxygenase-2 indirectly potentiates antitumor effects of photodynamic therapy in mice," Clin Cancer Res, 9(14), 5417-22 (2003).
24. Y. Akita, K. Kozaki, A. Nakagawa et al., "Cyclooxygenase-2 is a possible target of treatment approach in conjunction with photodynamic therapy for various disorders in skin and oral cavity," Br J Dermatol, 151(2), 472-80 (2004).
25. A. Ferrario, A. M. Fisher, N. Rucker et al., "Celecoxib and NS-398 enhance photodynamic therapy by increasing in vitro apoptosis and decreasing in vivo inflammatory and angiogenic factors," Cancer Res, 65(20), 9473-8 (2005).
26. E. H. Harvey, J. Webber, D. Kessel et al., "Killing tumor cells: the effect of photodynamic therapy using mono-L-aspartyl chlorine and NS-398," Am J Surg, 189(3), 302-5 (2005).
27. T. Nystrom, "Role of oxidative carbonylation in protein quality control and senescence," Embo J, 24(7), 1311-7 (2005).
28. M. Cattaruzza, and M. Hecker, "Protein carbonylation and decarboylation: a new twist to the complex response of vascular cells to oxidative stress," Circ Res, 102(3), 273-4 (2008).
29. T. Grune, T. Jung, K. Merker et al., "Decreased proteolysis caused by protein aggregates, inclusion bodies, plaques, lipofuscin, ceroid, and 'aggresomes' during oxidative stress, aging, and disease," Int J Biochem Cell Biol, 36(12), 2519-30 (2004).
30. A. Szokalska, M. Makowski, D. Nowis et al., "Proteasome Inhibition Potentiates Antitumor Effects of Photodynamic Therapy in Mice through Induction of Endoplasmic Reticulum Stress and Unfolded Protein Response," Cancer Res, (2009).
31. H. P. Wang, J. G. Hanlon, A. J. Rainbow et al., "Up-regulation of Hsp27 plays a role in the resistance of human colon carcinoma HT29 cells to photooxidative stress," Photochem Photobiol, 76(1), 98-104 (2002).
32. A. Jalili, M. Makowski, T. Switaj et al., "Effective photoimmunotherapy of murine colon carcinoma induced by the combination of photodynamic therapy and dendritic cells," Clin Cancer Res, 10(13), 4498-508 (2004).
33. M. Korbelik, J. Sun, and I. Cecic, "Photodynamic therapy-induced cell surface expression and release of heat shock proteins: relevance for tumor response," Cancer Res, 65(3), 1018-26 (2005).
34. A. Ferrario, N. Rucker, S. Wong et al., "Survivin, a member of the inhibitor of apoptosis family, is induced by photodynamic therapy and is a target for improving treatment response," Cancer Res, 67(10), 4989-95 (2007).
35. J. Wu, and R. J. Kaufman, "From acute ER stress to physiological roles of the Unfolded Protein Response," Cell Death Differ, 13(3), 374-84 (2006).
36. M. Schroder, and R. J. Kaufman, "The mammalian unfolded protein response," Annu Rev Biochem, 74, 739-89 (2005).
37. K. Romisch, "Endoplasmic reticulum-associated degradation," Annu Rev Cell Dev Biol, 21, 435-56 (2005).
38. E. Buytaert, G. Callewaert, J. R. Vandenheede et al., "Deficiency in apoptotic effectors Bax and Bak reveals an autophagic cell death pathway initiated by photodamage to the endoplasmic reticulum," Autophagy, 2(3), 238-40 (2006).
39. M. H. Glickman, and A. Ciechanover, "The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction," Physiol Rev, 82(2), 373-428 (2002).
40. E. Reinstein, and A. Ciechanover, "Narrative review: protein degradation and human diseases: the ubiquitin connection," Ann Intern Med, 145(9), 676-84 (2006).
41. C. Wojcik, and G. N. DeMartino, "Intracellular localization of proteasomes," Int J Biochem Cell Biol, 35(5), 579-89 (2003).
42. T. Grune, K. Merker, G. Sandig et al., "Selective degradation of oxidatively modified protein substrates by the proteasome," Biochem Biophys Res Commun, 305(3), 709-18 (2003).